Replies to post #5056 on Axim Biotechnologies Inc (AXIM)

[TexasMarvL]

Wow! This seems like a very generous offer to settle an issue that AXIM Management already stated they could win legally in court. $575,000 in cash (over time) and 20 MILLION shares???

Ouch! This hurts.
At least they are forced to hold the shares for a year and then have a limit of how many shares can be sold at one time.

[TexasMarvL]

Good Bad or Ugly, the settlement announced yesterday probably means AXIM will have all the debt converted to shares before the 2023-Year-End Report is released in April. Right???

However it is Q1 2024 already, so i guess the worst-case is the Q1 2024 10-Q report will definitely have a clear picture of the number of shares used up by debt conversion and Derivative Liability insufficient shares.

I sure hope Mr Kurt Phinney is still under contract and helping with the CLIA Waiver process and helping with the MMP-9 quantitative test submission to the FDA. The Parkinson Disease Point-of-Care test would fit great in the marketing agreement with Verséa Ophthalmics. Could AXIM be selling 4 FDA cleared Point-of-Care tests just 12 to 15 months from now??